These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Role of zinc and iron chelation in apoptosis mediated by tachpyridine, an anti-cancer iron chelator. Zhao R; Planalp RP; Ma R; Greene BT; Jones BT; Brechbiel MW; Torti FM; Torti SV Biochem Pharmacol; 2004 May; 67(9):1677-88. PubMed ID: 15081867 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of a class of 1,4,7-triazacyclononane derivatives as iron depletion antitumor agents. Wang S; Gai Y; Zhang S; Ke L; Ma X; Xiang G Bioorg Med Chem Lett; 2018 Jan; 28(2):117-121. PubMed ID: 29233652 [TBL] [Abstract][Full Text] [Related]
10. Antitumoral activity of 1,2-diaminocyclohexane derivatives in breast, colon and skin human cancer cells. Morales F; Ramírez A; Morata-Tarifa C; Navarro SA; Marchal JA; Campos JM; Conejo-García A Future Med Chem; 2017 Mar; 9(3):293-302. PubMed ID: 28176540 [TBL] [Abstract][Full Text] [Related]
11. Novel cytotoxic chelators that bind iron(II) selectively over zinc(II) under aqueous aerobic conditions. Planalp RP; Przyborowska AM; Park G; Ye N; Lu FH; Rogers RD; Broker GA; Torti SV; Brechbiel MW Biochem Soc Trans; 2002 Aug; 30(4):758-62. PubMed ID: 12196188 [TBL] [Abstract][Full Text] [Related]
12. Antibody conjugates of 7-ethyl-10-hydroxycamptothecin (SN-38) for targeted cancer chemotherapy. Moon SJ; Govindan SV; Cardillo TM; D'Souza CA; Hansen HJ; Goldenberg DM J Med Chem; 2008 Nov; 51(21):6916-26. PubMed ID: 18939816 [TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of endoperoxide-iron chelator conjugates-design, synthesis and biological evaluation. Yan X; Yu Y; Ji P; He H; Qiao C Eur J Med Chem; 2015 Sep; 102():180-7. PubMed ID: 26276433 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of 2-benzoylpyridine thiosemicarbazones in a dimeric system: structure-activity relationship studies on their anti-proliferative and iron chelation efficacy. Lukmantara AY; Kalinowski DS; Kumar N; Richardson DR J Inorg Biochem; 2014 Dec; 141():43-54. PubMed ID: 25217717 [TBL] [Abstract][Full Text] [Related]
15. Introducing Glycolinkers for the Functionalization of Cytotoxic Drugs and Applications in Antibody-Drug Conjugation Chemistry. Ekholm FS; Pynnönen H; Vilkman A; Pitkänen V; Helin J; Saarinen J; Satomaa T ChemMedChem; 2016 Nov; 11(22):2501-2505. PubMed ID: 27786414 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and characterization of novel iron chelators: structure-activity relationships of the 2-benzoylpyridine thiosemicarbazone series and their 3-nitrobenzoyl analogues as potent antitumor agents. Kalinowski DS; Yu Y; Sharpe PC; Islam M; Liao YT; Lovejoy DB; Kumar N; Bernhardt PV; Richardson DR J Med Chem; 2007 Jul; 50(15):3716-29. PubMed ID: 17602603 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of novel nicotinohydrazide and (1,3,4-oxadiazol-2-yl)-6-(trifluoromethyl)pyridine derivatives as potential anticancer agents. Naresh Kumar R; Poornachandra Y; Nagender P; Santhosh Kumar G; Krishna Swaroop D; Ganesh Kumar C; Narsaiah B Bioorg Med Chem Lett; 2016 Oct; 26(19):4829-4831. PubMed ID: 27561719 [TBL] [Abstract][Full Text] [Related]
18. 2-Acetylpyridine thiosemicarbazones are potent iron chelators and antiproliferative agents: redox activity, iron complexation and characterization of their antitumor activity. Richardson DR; Kalinowski DS; Richardson V; Sharpe PC; Lovejoy DB; Islam M; Bernhardt PV J Med Chem; 2009 Mar; 52(5):1459-70. PubMed ID: 19216562 [TBL] [Abstract][Full Text] [Related]
19. Novel chelating agents for potential clinical applications of copper. Ma D; Lu F; Overstreet T; Milenic DE; Brechbiel MW Nucl Med Biol; 2002 Jan; 29(1):91-105. PubMed ID: 11786280 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and Anti-Tumor Activities of 4-Anilinoquinoline Derivatives. Liu D; Luan T; Kong J; Zhang Y; Wang HF Molecules; 2015 Dec; 21(1):E21. PubMed ID: 26703559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]